• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Migraine-Associated Dizziness Is Elusive to Diagnose

by Alice Goodman • November 1, 2007

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Another good choice is sustained-release verapamil 120, 180, or 250 mg/day. Other antihypertensive agents that may be helpful include propranolol, 160 mg to 240 mg/day, and atenolol, 25 mg to 50 mg/day.

You Might Also Like

  • What Are the Diagnostic Criteria for Migraine-Associated Vertigo?
  • A Personal Spin on Migraine-Associated Vertigo Treatments: With few formal guidelines, otolaryngologists use trial and error
  • ESS Provides Better QOL for CRS Patients with Comorbid Migraine
  • 22 Symptoms Common to Patients with Superior Canal Dehiscence Syndrome
Explore This Issue
November 2007

If patients are hypertensive and on another antihypertensive agent, you will need to adjust medications. Be alert for low blood pressure, bradycardia, and low energy. Also, antihypertensive agents can exacerbate pre-existing depression, he said.

Topiramate, 50 mg twice a day in graduated doses, can also be used to treat migraine-associated dizziness. Side effects include paresthesias, nausea, fatigue, inattention, and weight loss.

If these medications are not effective, Dr. Goebel refers the patient to a neurologist. He emphasized that the triptans can abort acute migraine headache but are ineffective for migraine-associated dizziness.

Vestibular Rehabilitation for Migraine-Associated Dizziness

If migraine-associated dizziness is controlled with medications, then vestibular rehabilitation can be helpful, explained Kim R. Gottshall, PhD, Director of Vestibular Evaluation and Rehabilitation at the Spatial Orientation Center at the Naval Medical Center in San Diego.

Assessment tools include the following:

  • Dizziness Handicap Inventory (25 questions about emotional and functional problems)
  • Activity-Specific Balance Confidence scale (questions about tasks and confidence, such as walking up stairs, standing on toes, and walking up a ramp, escalator, icy sidewalk)
  • Dynamic Gait Index (assessing walking straight ahead, pivotal turn, and up and down stairs)
  • Tinetti Assessment Tool (assesses fall risk in elderly patients).

Once the patient is assessed using these tools, a customized exercise program can be developed for each patient. The various types of exercise address vestibulo-ocular reflex, cervico-ocular reflex, depth perception, somatosensory retraining, gait training, aerobic activity, core stability exercises, plyometrics, and return to sports and work.

©2007 The Triological Society

Pages: 1 2 3 | Single Page

Filed Under: Head and Neck, Otology/Neurotology Issue: November 2007

You Might Also Like:

  • What Are the Diagnostic Criteria for Migraine-Associated Vertigo?
  • A Personal Spin on Migraine-Associated Vertigo Treatments: With few formal guidelines, otolaryngologists use trial and error
  • ESS Provides Better QOL for CRS Patients with Comorbid Migraine
  • 22 Symptoms Common to Patients with Superior Canal Dehiscence Syndrome

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Have you experienced an increase in in-office rhinology procedures in the last year?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • ENTtoday Welcomes Resident Editorial Board Members
  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Popular this Week
  • Most Popular
  • Most Recent
    • History of the Cochlear Implant

    • Empty Nose Syndrome: Physiological, Psychological, or Perhaps a Little of Both?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • ChatGPT-Generated “Fake” References in Academic Manuscripts Is a Problem 

    • A Letter to My Younger Self: Making Deliberate Changes Can Help Improve the Sense of Belonging

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Questions on NIH Funding Leave ENT Researchers Pondering Next Steps and Leaving Everything Up in the Air
    • In-Office Rhinology Practices Continue to Grow
    • How Do We Define “Winning” in the OR?
    • A Letter to My Younger Self: Making Deliberate Changes Can Help Improve the Sense of Belonging
    • How To: Superior Maximization of Sphenoidotomy with Olfaction Preservation in Endoscopic Endonasal Surgery

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939